Literature DB >> 26323919

Decreased expression of miR-542-3p exerts growth inhibitory functions in esophageal cancer.

Bei-Bei Chen, Xiao-Bing Chen, Liang-Yu Bie, Yu Mu, Hai-Ling Wang, Hui-Fang Lv, Ning Li, Yi-Jie Ma, Zhi-Dan Ding, Su-Xia Luo1.   

Abstract

OBJECTIVE: Identification of novel biomarkers and related molecular pathways are critical for understanding the underlying biology of human malignancies, as well as to design effective cancer therapeutics. MicroRNAs (miRNAs) are classified as a kind of short non-coding RNAs that interfere with specific target mRNAs and therefore regulate multiple biological processes. We characterized here the expression and function of miR-542-3p in esophageal squamous cell carcinoma (ESCC).
METHODS: Real-time PCR was used to examine the miR-542-3p expression. After transfections of its synthetical mimics or inhibitor, cell growth rate was explored by cell counting assay. In addition, its expression was further statistically analyzed to reveal its association with clinical characters.
RESULTS: We show that miR-542-3p, a well-characterized tumor suppressor was significantly decreased in ESCC tissues and cell lines, whose downregulation is tightly associated with tumor grade. Furthermore, forced expression of miR-542-3p suppressed cell proliferation, while silencing its expression by a synthetical inhibitor could enhance cell growth rate.
CONCLUSION: Taken together, our results indicated that miR-542-3p is a tumor suppressor of esophageal cancer acting at steps that regulate cell growth.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26323919     DOI: 10.4103/0973-1482.163834

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  6 in total

1.  miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1.

Authors:  Long Yuan; Peng Yuan; Huijuan Yuan; Zhenlei Wang; Zengci Run; Guanglong Chen; Peng Zhao; Benling Xu
Journal:  Am J Cancer Res       Date:  2017-01-01       Impact factor: 6.166

2.  Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK.

Authors:  Heping Zhang; Jingfang Wang; Taoyuan Yu; Jingmin Wang; Jun Lu; Zongyang Yu
Journal:  PLoS One       Date:  2022-04-15       Impact factor: 3.752

3.  MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.

Authors:  Kristoffer Unterbruner; Frank Matthes; Judith Schilling; Rohit Nalavade; Stephanie Weber; Jennifer Winter; Sybille Krauß
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

4.  Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.

Authors:  R Venkatadri; T Muni; A K V Iyer; J S Yakisich; N Azad
Journal:  Cell Death Dis       Date:  2016-02-18       Impact factor: 8.469

5.  Identification of microRNAs and genes as biomarkers of atrial fibrillation using a bioinformatics approach.

Authors:  Yingyuan Li; Wulin Tan; Fang Ye; Faling Xue; Shaowei Gao; Wenqi Huang; Zhongxing Wang
Journal:  J Int Med Res       Date:  2019-06-20       Impact factor: 1.671

6.  MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling.

Authors:  Bin Qiao; Jing-Hua Cai; Alfred King-Yin Lam; Bao-Xia He
Journal:  Oncotarget       Date:  2017-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.